Related Experiment Video

Updated: Aug 4, 2026

A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes
05:18

A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes

Published on: February 17, 2023

Pathophysiological Role of Growth Factors in Diabetic Kidney Disease: Focus on Innovative Therapy

Flyvbjerg1, Hill, Logan

  • 1Medical Research Laboratory M and Medical Department M (Diabetes and Endocrinology), University of Aarhus, Aarhus Kommunehospital, DK-8000 Aarhus C, Denmark.

Trends in Endocrinology and Metabolism: TEM
|August 26, 1999
PubMed

Insights

Growth factors like growth hormone/insulin-like growth factor and transforming growth factor beta are implicated in diabetic kidney disease. Understanding these factors offers new therapeutic targets for diabetic complications.

Area of Science:

  • Endocrinology
  • Nephrology
  • Molecular Biology

Background:

  • Diabetic microvascular complications, particularly kidney disease, are a significant concern.
  • Growth factors play a complex role in the development of these complications.

Purpose of the Study:

  • To explore the role of specific growth factor systems in diabetic kidney disease.
  • To investigate potential therapeutic targets for diabetic kidney disease based on growth factor pathways.

Main Methods:

  • Review of current literature on growth factors in diabetic nephropathy.
  • Analysis of the growth hormone/insulin-like growth factor and transforming growth factor beta systems.
  • Examination of intrarenal mechanisms involved in diabetes-related kidney changes.

Main Results:

  • The growth hormone/insulin-like growth factor system influences diabetic kidney disease progression.
  • The transforming growth factor beta system is a key mediator of renal changes in diabetes.
  • These growth factors are involved in early renal alterations associated with diabetes.

Conclusions:

  • Growth factors are critical players in the pathogenesis of diabetic kidney disease.
  • Targeting these growth factor systems may lead to novel treatments for diabetic kidney disease.
  • Further research into these pathways could yield new drug development strategies.

More Related Videos

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice10:31

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice

Published on: May 2, 2025

Related Concept Videos

Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
Diabetic Foot Ulcer01:31

Diabetic Foot Ulcer

Definition A diabetic foot ulcer (DFU) is a chronic, non-healing wound that develops in individuals with diabetes. It typically occurs on pressure-bearing areas such as the heel, metatarsal heads, or hallux, and carries a high risk of infection and amputation.Pathophysiology • The development of DFUs can be explained by four interconnected mechanisms: neuropathy, ischemia, infection, and impaired wound healing. • Neuropathy is the most common factor. Sensory neuropathy reduces pain perception,...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...